Regatta Capital Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Regatta Capital Group's PFE Position: Q2 2026 in Review
Regatta Capital Group reduced its Pfizer (PFE) stake by 27% in Q2 2026, selling an estimated $84.2K and leaving 8,732 shares worth $210K. The position accounts for 0.03% of the portfolio, ranked #212.
Regatta Capital Group first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $507K in Q2 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Regatta Capital Group held 8,732 shares of Pfizer worth $210K as of Q2 2026.
- Regatta Capital Group sold 3,217 Pfizer shares in Q2 2026, an estimated $84.2K.
- Pfizer made up 0.03% of Regatta Capital Group's portfolio in Q2 2026, its #212 holding.
- Regatta Capital Group first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Regatta Capital Group's Pfizer position peaked at $507K in Q2 2025.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Regatta Capital Group's 13F filing for Q2 2026, filed 12 Aug 2026.